Your browser doesn't support javascript.
loading
[A single center study：An analysis of the safety and validity of delaying repeated biopsy for patients with atypical small acinar proliferation].
Ji, Wen-Tong; Liu, De-Chuan; Cui, Wan-Li; Hu, Yu; Wang, Yao; Tan, Jiu-Feng.
Afiliación
  • Ji WT; Department of Urology 2nd , China-Japan Union Hospital of Jilin University, Changchun, Jilin 130032, China.
  • Liu DC; Department of Urology 2nd , China-Japan Union Hospital of Jilin University, Changchun, Jilin 130032, China.
  • Cui WL; Department of Urology 2nd , China-Japan Union Hospital of Jilin University, Changchun, Jilin 130032, China.
  • Hu Y; Department of Pathology, China-Japan Union Hospital of Jilin University, Changchun, Jilin 130032, China.
  • Wang Y; Department of Urology 2nd , China-Japan Union Hospital of Jilin University, Changchun, Jilin 130032, China.
  • Tan JF; Jilin Key Laboratory of Molecular Diagnosis of Urologic Neoplasms, Changchun, Jilin 130032, China.
Zhonghua Nan Ke Xue ; 29(5): 414-419, 2023 May.
Article en Zh | MEDLINE | ID: mdl-38602757
ABSTRACT

OBJECTIVE:

To explore the association between atypical small acinar proliferation (ASAP) and subsequent diagnosis of intermediate and high risk prostate cancer (PCa), and analyze whether delaying repeat biopsy timing is safe and effective.

METHODS:

From June 2000 to June 2022, we retrospectively analyzed the clinical data of 276 patients accepting prostatic biopsy and diagnosed with ASAP in China-Japan Union Hospital of Jilin University. 54.7% (151/276) patients had a repeat biopsy. We used statistic methods to process the data.

RESULTS:

25.2%（38/151）patients were diagnosed with PCa on repeat biopsy. Among them, 78.9%（30/38）patients had Gleason score (GS) 3+3 and 21.1% (8/38) had GS 3+4 disease. There were 4 and 6 patients got RP respectively in the two cohorts. Only 5.3% (8/151) of ASAP patients were diagnosed as intermediate risk PCa in repeated biopsy and specially, no high risk PCa was identified in our study.

CONCLUSION:

It was safe and valid to delay the repeat biopsy.
Asunto(s)
Palabras clave
Buscar en Google
Añadir a Mi BVS
Imprimir
XML
PubMed Links

Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Estudios Retrospectivos Límite: Humans / Male País/Región como asunto: Asia Idioma: Zh Revista: Zhonghua Nan Ke Xue Asunto de la revista: MEDICINA REPRODUTIVA Año: 2023 Tipo del documento: Article País de afiliación: China Pais de publicación: China
Buscar en Google
Añadir a Mi BVS
Imprimir
XML
PubMed Links

Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Estudios Retrospectivos Límite: Humans / Male País/Región como asunto: Asia Idioma: Zh Revista: Zhonghua Nan Ke Xue Asunto de la revista: MEDICINA REPRODUTIVA Año: 2023 Tipo del documento: Article País de afiliación: China Pais de publicación: China